Organism: Homo sapiens
Gene: 38587_at
Selected probe(set): 207475_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 38587_at (207475_at) across 6674 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):-2.0594864
Number of Samples:5 / 5

Experimental	colorectal cancer study 33 (carcinoma; colonic mucosa)
	Colonic mucosa samples obtained by laser capture microdissection (LCM) from patients with colorectal carcinoma.
Control	normal colon mucosa sample
	Histopathological normal colon mucosa sample obtained by laser capture microdissection (LCM) from the distant normal colon of patients with colorectal cancer.

Relative Expression (log2-ratio):-1.8290682
Number of Samples:5 / 5

Experimental	colorectal adenoma study 7 (colonic mucosa)
	Colonic mucosa samples obtained by laser capture microdissection (LCM) from patients with colorectal adenoma.
Control	normal colon mucosa sample
	Histopathological normal colon mucosa sample obtained by laser capture microdissection (LCM) from the distant normal colon of patients with colorectal cancer.

Relative Expression (log2-ratio):-1.7064133
Number of Samples:10 / 6

Experimental	Crohn's disease study 3 (baseline; non-responder; ileum)
	Ileal mucosal biopsies derived from Crohn's disease patients who are non-responders to infliximab treatment. Biopsies were taken within a week prior to the first intravenous infusion of infliximab; the response to infliximab was assessed 4 to 6 weeks after the first infliximab treatment. The response was defined as a complete mucosal healing with a decrease of at least 3 points on the histological score for Crohn's disease (CDc) and as a decrease to a Mayo endoscopic subscore of 0 or 1 with a decrease to grade 0 or 1 on the histological score for ulcerative colitis (UC). More strict response criteria were used for Crohn's ileitis (CDi). More baseline information about the patients are available in the publication.
Control	normal ileum mucosa tissue
	Ileal mucosal biopsy from control subject obtained at the endoscopy for polyps screening.

Relative Expression (log2-ratio):-1.5692339
Number of Samples:5 / 5

Experimental	colorectal cancer study 33 (carcinoma; colonic crypt)
	Colonic crypt epithelial cell samples obtained by laser capture microdissection (LCM) from patients with colorectal carcinoma.
Control	normal colonic crypt epithelial cell sample
	Histopathological normal colonic crypt epithelial cells obtained by laser capture microdissection (LCM) from the distant normal colon of patients with colorectal cancer.

Relative Expression (log2-ratio):-1.4286814
Number of Samples:5 / 5

Experimental	colorectal cancer study 33 (carcinoma; colonic mucosa)
	Colonic mucosa samples obtained by laser capture microdissection (LCM) from patients with colorectal carcinoma.
Control	adjacent colon mucosa sample
	Adjacent colon mucosa sample obtained by laser capture microdissection (LCM) from patients with colorectal cancer.

Relative Expression (log2-ratio):-1.419014
Number of Samples:5 / 5

Experimental	colorectal adenoma study 7 (colonic crypt)
	Colonic crypt epithelial cell samples obtained by laser capture microdissection (LCM) from patients with colorectal adenoma.
Control	normal colonic crypt epithelial cell sample
	Histopathological normal colonic crypt epithelial cells obtained by laser capture microdissection (LCM) from the distant normal colon of patients with colorectal cancer.

Relative Expression (log2-ratio):-1.236124
Number of Samples:5 / 5

Experimental	colorectal cancer study 33 (carcinoma; colonic crypt)
	Colonic crypt epithelial cell samples obtained by laser capture microdissection (LCM) from patients with colorectal carcinoma.
Control	adjacent colonic crypt epithelial cell sample
	Adjacent colonic crypt epithelial cells obtained by laser capture microdissection (LCM) from patients with colorectal cancer.

Relative Expression (log2-ratio):-1.2113819
Number of Samples:4 / 3

Experimental	Crohn's disease study 10
	Colon biopsies derived from patients with Crohn's disease.
Control	normal colon tissue
	Colon biopsies derived from healthy controls.

Relative Expression (log2-ratio):-1.2023926
Number of Samples:4 / 2

Experimental	colorectal cancer study 33 (carcinoma; cecum)
	Primary tumor samples derived from the cecum of patients with carcinoma.
Control	normal cecum tissue
	Normal cecal tissue samples.

Relative Expression (log2-ratio):-1.1982632
Number of Samples:5 / 5

Experimental	colorectal adenoma study 7 (colonic mucosa)
	Colonic mucosa samples obtained by laser capture microdissection (LCM) from patients with colorectal adenoma.
Control	adjacent colon mucosa sample
	Adjacent colon mucosa sample obtained by laser capture microdissection (LCM) from patients with colorectal cancer.